UB Partners with Citiva on Medical Marijuana Research Program
Wednesday, January 13, 2016
Source: Buffalo Business First
Just days after the launch of New York’s medical marijuana program, the University at Buffalo has announced a new research initiative into medicinal cannabis in partnership with Citiva LLC.
With $1.65 million in funding from Citiva, UB’s Center for Integrated Global Health Sciences will work to develop new approaches to advance the study of medicinal cannabis and lead to greater knowledge on the therapeutic efficacy of cannabinoids in medicine.
Leading the effort is Gene Morse, director of the center and co-director of the SUNY Global Health Institute. Morse, who brings extensive international experience and funding in the field of HIV/AIDS, also directs the UB Drug Development Service and director of the new UB Center for Integrated Global Health Sciences.